Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06191198 · ClinicalTrials.gov registry record · Phase 2

Communication Bridge 3 Study

A Phase 2 study of Primary Progressive Aphasia, sponsored by University of Chicago.

Recruiting
Registry status
Phase 2
Development phase
200
Enrollment target
1
Study location

NCT06191198 is a Phase 2 study of Primary Progressive Aphasia that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 200 participants, above the 79-participant average among 15 other Primary Progressive Aphasia trials with a reported enrollment target (153% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06191198, a Phase 2 study of Primary Progressive Aphasia, is actively recruiting participants, sponsored by University of Chicago.

RECRUITING
Registry status
Phase 2
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

This study will use a randomized controlled trial design to evaluate the effect of two evidence-based treatments for adults with mild-moderate Primary Progressive Aphasia (PPA). The aim of the study is to help us better understand the effects of speech-language therapy on communication abilities in individuals with PPA.

Conditions Studied

Primary Progressive Aphasia

Interventions

  • BEHAVIORAL Communication Bridge™
  • BEHAVIORAL Evidence-Based Impairment Focused

Study Locations (1)

Illinois

  • University of Chicago - American School Building - Chicago

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2024-08-23
Est. Completion 2028-07-15
Phase Phase 2

Sponsor

University of Chicago

796 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06191198

The ClinicalTrials.gov registry entry for NCT06191198 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 79-participant average among 15 other Primary Progressive Aphasia trials with a reported enrollment target (153% higher). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Primary Progressive Aphasia appearing as the primary indexed condition, and to 2 interventions - of which Communication Bridge™ is the first listed.

NCT06191198 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06191198 about?

NCT06191198 is a clinical study titled "Communication Bridge 3 Study". This study will use a randomized controlled trial design to evaluate the effect of two evidence-based treatments for adults with mild-moderate Primary Progressive Aphasia (PPA). The aim of the study is to help us better understand the effects of speech-language therapy on communication abilities in ...

What is the current status of trial NCT06191198?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2024-08-23. Estimated completion is 2028-07-15.

What conditions does trial NCT06191198 study?

This clinical trial studies the following conditions: Primary Progressive Aphasia.

What interventions are being tested in trial NCT06191198?

The interventions under investigation include: Communication Bridge™ (BEHAVIORAL), Evidence-Based Impairment Focused (BEHAVIORAL).

Who is sponsoring clinical trial NCT06191198?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06191198 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Primary Progressive Aphasia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Primary Progressive Aphasia

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.